Guerbet

GBTFR0000032526

Guerbet is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.

Filings

7 filings

All Inside information23 Voting rights and capital18 Earnings release14 Share buyback7 Universal registration document5 Corporate governance4 Half-year financial report1 Threshold crossing1

09/07/2026
GUERBET : Bilan semestriel du contrat de liquidité
Share buybackFrench
19/01/2026
GUERBET : Bilan semestriel du contrat de liquidité
Share buybackFrench
25/07/2025
GUERBET : Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte du 23 mai 2025
Share buybackFrench
09/07/2025
GUERBET : Bilan semestriel du contrat de liquidité
Share buybackFrench
03/02/2025
GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF
Share buybackFR
17/01/2025
GUERBET : Bilan semestriel du contrat de liquidité
Share buybackFrench

About

ISIN: FR0000032526
Ticker: GBT
LEI: 969500WV1U1WQ059L135
Founded: 1926
Country of registration: FR
Last filing: 23/07/2026, 17:45

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive